Ocugen to Host Conference Call on Friday, November 8 at 8:30 A.M. ET to Discuss Business Updates and Third Quarter 2024 Financial Results

Core Viewpoint - Ocugen, Inc. is set to host a conference call and live webcast on November 8, 2024, to discuss its third quarter 2024 financial results and provide a business update [1][2]. Company Overview - Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines aimed at improving health and offering hope to patients globally [3]. - The company is advancing a breakthrough modifier gene therapy platform that has the potential to treat multiple retinal diseases with a single product, alongside research in infectious and orthopedic diseases to address unmet medical needs [3]. Conference Call Details - The pre-market earnings announcement will coincide with the conference call on November 8, 2024 [2]. - Dial-in numbers for the call are (800) 715-9871 for U.S. callers and (646) 307-1963 for international callers, with a Conference ID of 9923172 [2]. - A replay of the call and archived webcast will be available for approximately 45 days following the event on the Ocugen investor site [2].